MYC upregulates 3-hydroxy-3-methyl-glutaryl coenzyme A reductase (HMGCR), the rate-limiting enzyme in cholesterol biosynthesis, further enhancing tumor cell proliferation and survival 151. This evidence concerns the gene MYC and neoplasm.